Heparan sulfate: A ubiquitous glycosaminoglycan with multiple roles in immunity

Frontiers in Immunology

Volumn 4, Issue DEC, 2013, Pages

  Simon Davis, David Anak ^a   Parish, Christopher R ^a  

^a Biology and Environment   (Australia)

Author keywords

Glycosaminoglycan; Hematopoiesis; Heparan sulfate; Heparanase; Homing; Inflammation

Indexed keywords

EID: 84892164539     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00470     Document Type: Short Survey

References (84)

1. Kreuger J, Kjellen L. Heparan sulfate biosynthesis: regulation and variability. J Histochem Cytochem (2012) 60(12):898-907. doi:10.1369/0022155412464972
2. Esko JD, Selleck SB. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem (2002) 71:435-71. doi:10.1146/annurev.biochem.71.110601.135458
3. Peterson SB, Liu J. Unraveling the specificity of heparanase utilizing synthetic substrates. J Biol Chem (2010) 285(19):14504-13. doi:10.1074/jbc.M110.104166
4. Nagamine S, Tamba M, Ishimine H, Araki K, Shiomi K, Okada T, et al. Organ-specific sulfation patterns of heparan sulfate generated by extracellular sulfatases Sulf1 and Sulf2 in mice. J Biol Chem (2012) 287(12):9579-90. doi:10.1074/jbc.M111.290262
5. Hossain MM, Hosono-Fukao T, Tang R, Sugaya N, van Kuppevelt TH, Jenniskens GJ, et al. Direct detection of HSulf-1 and HSulf-2 activities on extracellular heparan sulfate and their inhibition by PI-88. Glycobiology (2010) 20(2):175-86. doi:10.1093/glycob/cwp159
6. Uchimura K, Morimoto-Tomita M, Bistrup A, Li J, Lyon M, Gallagher J, et al. HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. BMC Biochem (2006) 7:2. doi:10.1186/1471-2091-7-2
7. Kramer KL, Yost HJ. Heparan sulfate core proteins in cell-cell signaling. Annu Rev Genet (2003) 37:461-84. doi:10.1146/annurev.genet.37.061103.090226
8. Sarrazin S, Lamanna WC, Esko JD. Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol (2011) 3(7):1-33. doi:10.1101/cshperspect.a004952
9. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, et al. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem (1999) 68:729-77. doi:10.1146/annurev.biochem.68.1.729
10. Parish CR. The role of heparan sulphate in inflammation. Nat Rev Immunol (2006) 6(9):633-43. doi:10.1038/nri1918
11. Kolset SO, Pejler G. Serglycin: a structural and functional chameleon with wide impact on immune cells. J Immunol (2011) 187(10):4927-33. doi:10.4049/jimmunol.1100806
12. Richardson TP, Trinkaus-Randall V, Nugent MA. Regulation of heparan sulfate proteoglycan nuclear localization by fibronectin. J Cell Sci (2001) 114(Pt 9):1613-23.
13. Fedarko NS, Conrad HE. A unique heparan sulfate in the nuclei of hepatocytes: structural changes with the growth state of the cells. J Cell Biol (1986) 102(2):587-99. doi:10.1083/jcb.102.2.587
14. Buczek-Thomas JA, Hsia E, Rich CB, Foster JA, Nugent MA. Inhibition of histone acetyltransferase by glycosaminoglycans. J Cell Biochem (2008) 105(1):108-20. doi:10.1002/jcb.21803
15. Purushothaman A, Hurst DR, Pisano C, Mizumoto S, Sugahara K, Sanderson RD. Heparanase-mediated loss of nuclear syndecan-1 enhances histone acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotype. J Biol Chem (2011) 286(35):30377-83. doi:10.1074/jbc.M111.254789
16. Chen L, Sanderson RD. Heparanase regulates levels of syndecan-1 in the nucleus. PLoS One (2009) 4(3):e4947. doi:10.1371/journal.pone.0004947
17. Hileman RE, Fromm JR, Weiler JM, Linhardt RJ. Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays (1998) 20(2):156-67. doi:10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-\#
18. Cardin AD, Weintraub HJ. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis (1989) 9(1):21-32. doi:10.1161/01.ATV.9.1.21
19. Lu CP, Sandoval H, Brandt VL, Rice PA, Roth DB. Amino acid residues in Rag1 crucial for DNA hairpin formation. Nat Struct Mol Biol (2006) 13(11):1010-5. doi:10.1038/nsmb1154
20. Johnson GB, Brunn GJ, Kodaira Y, Platt JL. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol (2002) 168(10):5233-9.
21. Wuillemin WA, te Velthuis H, Lubbers YT, de Ruig CP, Eldering E, Hack CE. Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma. J Immunol (1997) 159(4):1953-60.
22. Sahu A, Pangburn MK. Identification of multiple sites of interaction between heparin and the complement system. Mol Immunol (1993) 30(7):679-84. doi:10.1016/0161-5890(93)90079-Q
23. Presanis JS, Hajela K, Ambrus G, Gal P, Sim RB. Differential substrate and inhibitor profiles for human MASP-1 and MASP-2. Mol Immunol (2004) 40(13):921-9. doi:10.1016/j.molimm.2003.10.013
24. Diamond MS, Alon R, Parkos CA, Quinn MT, Springer TA. Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD1). J Cell Biol (1995) 130(6):1473-82. doi:10.1083/jcb.130.6.1473
25. Vorup-Jensen T, Chi L, Gjelstrup LC, Jensen UB, Jewett CA, Xie C, et al. Binding between the integrin alphaXbeta2 (CD11c/CD18) and heparin. J Biol Chem (2007) 282(42):30869-77. doi:10.1074/jbc.M706114200
26. Zaferani A, Talsma D, Richter MK, Daha MR, Navis GJ, Seelen MA, et al. Heparin/heparan sulphate interactions with complement-a possible target for reduction of renal function loss? Nephrol Dial Transplant (2013) 1-9. doi:10.1093/ndt/gft243
27. Hacker U, Nybakken K, Perrimon N. Heparan sulphate proteoglycans: the sweet side of development. Nat Rev Mol Cell Biol (2005) 6(7):530-41. doi:10.1038/nrm1681
28. Bishop JR, Schuksz M, Esko JD. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature (2007) 446(7139):1030-7. doi:10.1038/nature05817
29. Lindahl U, Kjellen L. Pathophysiology of heparan sulphate: many diseases, few drugs. J Intern Med (2013) 273(6):555-71. doi:10.1111/joim.12061
30. Coombe DR, Watt SM, Parish CR. Mac-1 (CD11b/CD18) and CD45 mediate the adhesion of hematopoietic progenitor cells to stromal cell elements via recognition of stromal heparan sulfate. Blood (1994) 84(3):739-52.
31. Khurana S, Margamuljana L, Joseph C, Schouteden S, Buckley SM, Verfaillie CM. Glypican-3-mediated inhibition of CD26 by TFPI: a novel mechanism in hematopoietic stem cell homing and maintenance. Blood (2013) 121(14):2587-95. doi:10.1182/blood-2012-09-456715
32. Werneck CC, Oliveira-Dos-Santos AJ, Silva LC, Villa-Verde DM, Savino W, Mourao PA. Thymic epithelial cells synthesize a heparan sulfate with a highly sulfated region. J Cell Physiol (1999) 178(1):51-62. doi:10.1002/(SICI)1097-4652(199901)178:1<51::AID-JCP7>3.3.CO;2-K
33. Werneck CC, Cruz MS, Silva LC, Villa-Verde DM, Savino W, Mourao PA. Is there a glycosaminoglycan-related heterogeneity of the thymic epithelium? J Cell Physiol (2000) 185(1):68-79. doi:10.1002/1097-4652(200010)185:1<68::AID-JCP6>3.0.CO;2-D
34. Oliveira-dos-Santos AJ, Penninger JM, Rieker-Geley T, Matsumoto G, Mak TM, Wick G. Thymic heterotypic cellular complexes in gene-targeted mice with defined blocks in T cell development and adhesion molecule expression. Eur J Immunol (1998) 28(9):2882-92. doi:10.1002/(SICI)1521-4141(199809)28:09<2882::AID-IMMU2882>3.0.CO;2-1
35. Oliveira-dos-Santos AJ, Rieker-Geley T, Recheis H, Wick G. Murine thymic nurse cells and rosettes: analysis of adhesion molecule expression using confocal microscopy and a simplified enrichment method. J Histochem Cytochem (1997) 45(9):1293-7. doi:10.1177/002215549704500912
36. Wang L, Fuster M, Sriramarao P, Esko JD. Endothelial heparan sulfate deficiency impairs L-selectin-and chemokine-mediated neutrophil trafficking during inflammatory responses. Nat Immunol (2005) 6(9):902-10. doi:10.1038/ni1233
37. Zen K, Liu DQ, Li LM, Chen CX, Guo YL, Ha B, et al. The heparan sulfate proteoglycan form of epithelial CD44v3 serves as a CD11b/CD18 counter-receptor during polymorphonuclear leukocyte transepithelial migration. J Biol Chem (2009) 284(6):3768-76. doi:10.1074/jbc.M807805200
38. Kawashima H, Watanabe N, Hirose M, Sun X, Atarashi K, Kimura T, et al. Collagen XVIII, a basement membrane heparan sulfate proteoglycan, interacts with L-selectin and monocyte chemoattractant protein-1. J Biol Chem (2003) 278(15):13069-76. doi:10.1074/jbc.M212244200
39. Celie JW, Keuning ED, Beelen RH, Drager AM, Zweegman S, Kessler FL, et al. Identification of L-selectin binding heparan sulfates attached to collagen type XVIII. J Biol Chem (2005) 280(29):26965-73. doi:10.1074/jbc.M502188200
40. Schmidt EP, Yang Y, Janssen WJ, Gandjeva A, Perez MJ, Barthel L, et al. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med (2012) 18(8):1217-23. doi:10.1038/nm.2843
41. Giuffre L, Cordey AS, Monai N, Tardy Y, Schapira M, Spertini O. Monocyte adhesion to activated aortic endothelium: role of L-selectin and heparan sulfate proteoglycans. J Cell Biol (1997) 136(4):945-56. doi:10.1083/jcb.136.4.945
42. Kharabi Masouleh B, Ten Dam GB, Wild MK, Seelige R, van der Vlag J, Rops AL, et al. Role of the heparan sulfate proteoglycan syndecan-1 (CD138) in delayed-type hypersensitivity. J Immunol (2009) 182(8):4985-93. doi:10.4049/jimmunol.0800574
43. Handel TM, Johnson Z, Crown SE, Lau EK, Proudfoot AE. Regulation of protein function by glycosaminoglycans-as exemplified by chemokines. Annu Rev Biochem (2005) 74:385-410. doi:10.1146/annurev.biochem.72.121801.161747
44. Coombe DR. Biological implications of glycosaminoglycan interactions with haemopoietic cytokines. Immunol Cell Biol (2008) 86(7):598-607. doi:10.1038/icb.2008.49
45. Clarke D, Katoh O, Gibbs RV, Griffiths SD, Gordon MY. Interaction of interleukin 7 (IL-7) with glycosaminoglycans and its biological relevance. Cytokine (1995) 7(4):325-30. doi:10.1006/cyto.1995.0041
46. Lortat-Jacob H, Grimaud JA. Interferon-gamma C-terminal function: new working hypothesis. Heparan sulfate and heparin, new targets for IFN-gamma, protect, relax the cytokine and regulate its activity. Cell Mol Biol (1991) 37(3):253-60.
47. Borghesi LA, Yamashita Y, Kincade PW. Heparan sulfate proteoglycans mediate interleukin-7-dependent B lymphopoiesis. Blood (1999) 93(1):140-8.
48. Banwell CM, Partington KM, Jenkinson EJ, Anderson G. Studies on the role of IL-7 presentation by mesenchymal fibroblasts during early thymocyte development. Eur J Immunol (2000) 30(8):2125-9. doi:10.1002/1521-4141(2000)30:8<2125::AID-IMMU2125>3.0.CO;2-H
49. Sadir R, Forest E, Lortat-Jacob H. The heparan sulfate binding sequence of interferon-gamma increased the on rate of the interferon-gamma-interferon-gamma receptor complex formation. J Biol Chem (1998) 273(18):10919-25. doi:10.1074/jbc.273.18.10919
50. Miller JD, Stevens ET, Smith DR, Wight TN, Wrenshall LE. Perlecan: a major IL-2-binding proteoglycan in murine spleen. Immunol Cell Biol (2008) 86(2):192-9. doi:10.1038/sj.icb.7100128
51. Miller JD, Clabaugh SE, Smith DR, Stevens RB, Wrenshall LE. Interleukin-2 is present in human blood vessels and released in biologically active form by heparanase. Immunol Cell Biol (2012) 90(2):159-67. doi:10.1038/icb.2011.45
52. Proudfoot AE, Handel TM, Johnson Z, Lau EK, LiWang P, Clark-Lewis I, et al. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc Natl Acad Sci U S A (2003) 100(4):1885-90. doi:10.1073/pnas.0334864100
53. Salanga CL, Handel TM. Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function. Exp Cell Res (2011) 317(5):590-601. doi:10.1016/j.yexcr.2011.01.004
54. Laguri C, Arenzana-Seisdedos F, Lortat-Jacob H. Relationships between glycosaminoglycan and receptor binding sites in chemokines-the CXCL12 example. Carbohydr Res (2008) 343(12):2018-23. doi:10.1016/j.carres.2008.01.047
55. Hoogewerf AJ, Kuschert GS, Proudfoot AE, Borlat F, Clark-Lewis I, Power CA, et al. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry (1997) 36(44):13570-8. doi:10.1021/bi971125s
56. Massena S, Christoffersson G, Hjertstrom E, Zcharia E, Vlodavsky I, Ausmees N, et al. A chemotactic gradient sequestered on endothelial heparan sulfate induces directional intraluminal crawling of neutrophils. Blood (2010) 116(11):1924-31. doi:10.1182/blood-2010-01-266072
57. Weber M, Hauschild R, Schwarz J, Moussion C, de Vries I, Legler DF, et al. Interstitial dendritic cell guidance by haptotactic chemokine gradients. Science (2013) 339(6117):328-32. doi:10.1126/science.1228456
58. Bao X, Moseman EA, Saito H, Petryniak B, Thiriot A, Hatakeyama S, et al. Endothelial heparan sulfate controls chemokine presentation in recruitment of lymphocytes and dendritic cells to lymph nodes. Immunity (2010) 33(5):817-29. doi:10.1016/j.immuni.2010.10.018
59. Tsuboi K, Hirakawa J, Seki E, Imai Y, Yamaguchi Y, Fukuda M, et al. Role of high endothelial venule-expressed heparan sulfate in chemokine presentation and lymphocyte homing. J Immunol (2013) 191(1):448-55. doi:10.4049/jimmunol.1203061
60. Hayashida K, Parks WC, Park PW. Syndecan-1 shedding facilitates the resolution of neutrophilic inflammation by removing sequestered CXC chemokines. Blood (2009) 114(14):3033-43. doi:10.1182/blood-2009-02-204966
61. Axelsson J, Xu D, Kang BN, Nussbacher JK, Handel TM, Ley K, et al. Inactivation of heparan sulfate 2-O-sulfotransferase accentuates neutrophil infiltration during acute inflammation in mice. Blood (2012) 120(8):1742-51. doi:10.1182/blood-2012-03-417139
62. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol (2008) 8(4):279-89. doi:10.1038/nri2215
63. Xu D, Young JH, Krahn JM, Song D, Corbett KD, Chazin WJ, et al. Stable RAGE-heparan sulfate complexes are essential for signal transduction. ACS Chem Biol (2013) 1611-20. doi:10.1021/cb4001553
64. Xu D, Young J, Song D, Esko JD. Heparan sulfate is essential for high mobility group protein 1 (HMGB1) signaling by the receptor for advanced glycation end products (RAGE). J Biol Chem (2011) 286(48):41736-44. doi:10.1074/jbc.M111.299685
65. Poon IK, Parish CR, Hulett MD. Histidine-rich glycoprotein functions cooperatively with cell surface heparan sulfate on phagocytes to promote necrotic cell uptake. J Leukoc Biol (2010) 88(3):559-69. doi:10.1189/jlb.0210087
66. Ihrcke NS, Wrenshall LE, Lindman BJ, Platt JL. Role of heparan sulfate in immune system-blood vessel interactions. Immunol Today (1993) 14(10):500-5. doi:10.1016/0167-5699(93)90265-M
67. Wrenshall LE, Stevens RB, Cerra FB, Platt JL. Modulation of macrophage and B cell function by glycosaminoglycans. J Leukoc Biol (1999) 66(3):391-400.
68. Kodaira Y, Nair SK, Wrenshall LE, Gilboa E, Platt JL. Phenotypic and functional maturation of dendritic cells mediated by heparan sulfate. J Immunol (2000) 165(3):1599-604.
69. Akbarshahi H, Axelsson JB, Said K, Malmstrom A, Fischer H, Andersson R. TLR4 dependent heparan sulphate-induced pancreatic inflammatory response is IRF3-mediated. J Transl Med (2011) 9:219. doi:10.1186/1479-5876-9-219
70. Johnson GB, Brunn GJ, Platt JL. Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4. J Immunol (2004) 172(1):20-4.
71. Brennan TV, Lin L, Huang X, Cardona DM, Li Z, Dredge K, et al. Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantation. Blood (2012) 120(14):2899-908. doi:10.1182/blood-2011-07-368720
72. Strand ME, Herum KM, Rana ZA, Skrbic B, Askevold ET, Dahl CP, et al. Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart. FEBS J (2013) 280(10):2228-47. doi:10.1111/febs.12161
73. Vlodavsky I, Eldor A, Haimovitz-Friedman A, Matzner Y, Ishai-Michaeli R, Lider O, et al. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis (1992) 12(2):112-27.
74. Benhamron S, Nechushtan H, Verbovetski I, Krispin A, Abboud-Jarrous G, Zcharia E, et al. Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells. J Immunol (2006) 176(11):6417-24.
75. Benhamron S, Reiner I, Zcharia E, Atallah M, Grau A, Vlodavsky I, et al. Dissociation between mature phenotype and impaired transmigration in dendritic cells from heparanase-deficient mice. PLoS One (2012) 7(5):e35602. doi:10.1371/journal.pone.0035602
76. Matzner Y, Bar-Ner M, Yahalom J, Ishai-Michaeli R, Fuks Z, Vlodavsky I. Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes. J Clin Invest (1985) 76(4):1306-13. doi:10.1172/JCI112104
77. Sasaki N, Higashi N, Taka T, Nakajima M, Irimura T. Cell surface localization of heparanase on macrophages regulates degradation of extracellular matrix heparan sulfate. J Immunol (2004) 172(6):3830-5.
78. Ziolkowski AF, Popp SK, Freeman C, Parish CR, Simeonovic CJ. Heparan sulfate and heparanase play key roles in mouse beta cell survival and autoimmune diabetes. J Clin Invest (2012) 122(1):132-41. doi:10.1172/JCI46177
79. Rees MD, Whitelock JM, Malle E, Chuang CY, Iozzo RV, Nilasaroya A, et al. Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan. Matrix Biol (2010) 29(1):63-73. doi:10.1016/j.matbio.2009.09.005
80. Vilar RE, Ghael D, Li M, Bhagat DD, Arrigo LM, Cowman MK, et al. Nitric oxide degradation of heparin and heparan sulphate. Biochem J (1997) 324(Pt 2):473-9.
81. Mani K, Jonsson M, Edgren G, Belting M, Fransson LA. A novel role for nitric oxide in the endogenous degradation of heparan sulfate during recycling of glypican-1 in vascular endothelial cells. Glycobiology (2000) 10(6):577-86. doi:10.1093/glycob/10.6.577
82. Rao G, Ding HG, Huang W, Le D, Maxhimer JB, Oosterhof A, et al. Reactive oxygen species mediate high glucose-induced heparanase-1 production and heparan sulphate proteoglycan degradation in human and rat endothelial cells: a potential role in the pathogenesis of atherosclerosis. Diabetologia (2011) 54(6):1527-38. doi:10.1007/s00125-011-2110-z
83. Singh A, Ramnath RD, Foster RR, Wylie EC, Friden V, Dasgupta I, et al. Reactive oxygen species modulate the barrier function of the human glomerular endothelial glycocalyx. PLoS One (2013) 8(2):e55852. doi:10.1371/journal.pone.0055852
84. Raats CJ, Bakker MA, van den Born J, Berden JH. Hydroxyl radicals depolymerize glomerular heparan sulfate in vitro and in experimental nephrotic syndrome. J Biol Chem (1997) 272(42):26734-41. doi:10.1074/jbc.272.42.26734